Business description
CytoTools AG is a biotechnology company focused on translating fundamental biology research on the mechanisms of cell growth and programmed cell death into unique therapies that are designed to treat the cause of the disease rather than the symptoms. The Company has developed a robust and diverse pipeline of disease modifying therapies that comprise proprietary small molecules and biologics. These have the potential to provide new treatment options in dermatology, cardiology and angiology, urology and oncology.
Management board & Supervisory board
| CEO |
| Dr. Mark-Andre Freyberg |
| Management board |
| Marc Herwick, Dr. Dirk Kaiser |
| Supervisory board |
| Dr. Bernhard Seehaus, Dr. Manfred May, Dr. Rüdiger Weseloh, Heiner Hoppmann, Matthias Hoffmann |
Company data
| Name: |
CytoTools AG |
| Address: |
Klappacher Straße 126,D-64285 Darmstadt |
| Phone: |
+49-6151-951-5812 |
| Fax: |
+49-6151-951-5813 |
| E-mail: |
kontakt@cytotools.de
|
| Internet: |
www.cytotools.de/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
53.00% |
| IPO date: |
- |
Investor relations
| Name: |
Dr. Mark-Andre Freyberg |
| IR phone: |
- |
| IR Fax: |
- |
| IR e-mail: |
-
|
